Anti-BCMA CAR T Cells are a BCMA targeted CAR T Cell therapy being developed at the National Cancer Institute.
| SparkCures ID | 127 |
|---|---|
| Generic Name | Anti-BCMA CAR T Cells |
| Treatment Classifications |
|
| Treatment Targets |
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
There are no resources, links or videos to display for this treatment.